SUMMARY Percutaneous transluminal coronary angioplasty (PTCA) was performed in 21 patients with acute myocardial infarction (AMI) treated by intracoronary infusion of streptokinase within 8 hours after the onset of symptoms. Streptolysis therapy began a mean of 3.6 1.2 hours (±+ SD) after the onset of symptoms. The vessel was occluded in 14 patients and highly stenosed in seven. After the infusion of 67,300 + 63,200 IU of streptokinase over 26.1 21.5 minutes, patency of the occluded vessels was reached.
, after an initial unsuccessful application of 90,000 IU of streptokinase, an additional 165,000 IU of urokinase opened the vessel. After reperfusion of the vessel, which was seen angiographically, an additional 81,100 ± 34,300 IU of steptokinase (range 30,000-135,000 IU) were infused within the next 15-57 minutes (mean 34.1 ± 15.6 minutes). In patient 14, the infusion was stopped immediately after the vessel became patent. In seven patients with spontaneously reopened vessels, 60,000-120,000 IU of streptokinase (mean 85,000 ± 26,300 IU) were applied because residual thrombotic material could not always be excluded angiographically. The total amount of streptokinase varied between 60,000 and 255,000 lU (mean 126,000 ± 47,900 IU). No intracoronary manipulation with guidewires or other material was practiced during lysis or before PTCA. In 10 of 14 patients with total occlusion, pain was relieved when the vessel was reopened.
In group B, 10 patients had still occluded and eight spontaneously recanalized but stenotic vessels (table 2). In the group with occlusion, the vessels were patent after an infusion time of 49.0 ± 21.8 minutes with an average of 98,000 + 43,700 IU of streptokinase. After patency was reached, an additional 80,000 ± 20,000 IU were infused.
PTCA Technique
In 19 of 21 patients in group A (table 3) , PTCA was performed within the same session 20-60 minutes after the streptokinase infusion. In two patients (nos. 2 and 9), PTCA was performed in a second session 31 hours and 24 hours later, respectively. Through a #9F, 16-cm-long introducing sheath (USCI), a guiding catheter (Schneider-Medintag) was advanced from the groin to the ostium of the diseased vessel. The dilation catheter (Schneider-Medintag) was directed into the stenotic area under fluoroscopic and pressure control. The size of the balloon catheter was chosen according to the width of the unstenosed part of the vessel. In six of the 17 successfully treated cases, its outer diameter was 3 mm and in 11 cases 3.7 mm. Three to 11 balloon inflations were performed over 10-28 seconds (mean 15.7 ± 4.7 seconds) at a pressure rate of 72.5-94.3 psi (mean 88.5 ± 5.8 psi). The sheath was left in place for the next 36-48 hours, while the patients were monitored in the coronary care unit. During this time, heparmn, 1000 U/hour, was infused continuously. All successfully treated patients were given coumarin until the follow-up study.
Calculation of Stenoses
In all patients of groups A and B, the stenotic vessel areas were filmed and recorded on videotape in two different projections in stenoses of the RCA and the LCx and in at least three projections, including one craniocaudal, in stenoses of the LAD. From projection of the cinefilm magnified 20-fold, the degree of stenosis was calculated using a computer-based, ultrasonic pen system. Calculations were given in terms of per- In the control patients treated only with streptokinase (table 2), the degree of vessel obstruction was comparable to that in PTCA patients. The mean value of the area obstruction was 88.9 + 5.5% and that of the luminal diameter was 67.9 ± 8. 1%. These values were not significantly different from those of the PTCA group.
Complications
Six patients had ventricular extrasystoles, one ventricular tachycardia and one atrial fibrillation during streptokinase infusion. Four had a slow idioventricular rhythm and one ventricular fibrillation at the beginning of reperfusion (table 1) . Eight patients were permanently in stable sinus rhythm. During the PTCA procedure, no acute vessel obstruction or dissection occuffed that might have necessitated emergency bypass surgery. There was no major rhythm disturbance during or after the PTCA procedure. Severe bleeding that necessitated blood transfusion or operative intervention did not occur. One patient (no. 2, group B) who was not immediately treated with PTCA developed complete cardiogenic shock 31 hours after streptolysis. Thirty minutes after successful dilation of the severe RCA stenosis (96% vessel area, 80% luminal diameter) the shock vanished. She left the hospital in functional class I (Canadian Cardiovascular Society criteria).
Hospital Stay and Follow-up
The hospital course and the follow-up course were analyzed for each patient in both groups (tables 2 and 3). Three of the unsuccessfully treated patients (nos. 1, 10 and 21) of the PTCA group A and one patient with a borderline dilation result (no. 5) received bypass surgery 48-72 hours later. One unsuccessfully treated patient (no. 3) did not undergo bypass surgery, as his clinical condition was poor and he had diffuse coronary atherosclerosis. He suffered a reinfarction 6 weeks later. At hospital discharge and 6 months later, he was in functional class IV. l0 Nineteen patients were discharged. Fourteen were in class I and three in class II; one patient was in class III and one in class IV (table  3) . Two days after successful treatment, patient 8 died from cardiac tamponade due to diffuse epicardial bleeding. At autopsy, the diseased vessel was still patent. Patient 12 experienced complete reocclusion of the vessel after 25 days at the same site. He underwent streptolysis and dilation again (patient 14) and was discharged with symptoms of class I. (For the second procedure this patient was considered separately as patient 14).
Patient 13 developed angina 2 weeks later. A restenosis at the site of the previous occlusion was dilated again. During this second PTCA, she experienced severe vasospasm at various sites of the coronary system despite pretreatment with nifedipine. The vasospasm was relieved by intracoronary nifedipine, verapamil and nitroglycerin. Twelve successfully treated patients were restudied angiographically after 6 months. In 11, the vessels were patent. One had an asymptomatic reocclusion (table 3) . Patient (table 2) , four patients had a the surviving patients treated medically were in class II reinfarction during the hospital course. At discharge, and three in class III. nine patients were in class II, five in class III and four in class IV. Within 2-8 months, three patients died, Discussion one from a reocclusion of the LAD and two from Selective intracoronary application of streptokinase sudden death. Three patients underwent an elective or urokinase within 6-8 hours after occlusion has been 19 20 21 26 Although the control group of 18 patients treated only with streptokinase was not randomized, it may act as a reference for the combined streptokinase-PTCA procedure. These patients were selected from 37 patients in whom streptokinase treatment was successful angiographically. Analysis of the cinefilms showed retrospectively that they were candidates for PTCA. This group did not differ significantly from the PTCA group with respect to age, coronary morphology, treatment with streptokinase and amount of vessel obstruction. Their clinical course, however, was much more complicated than that of the PTCA group. During the hospital course, four patients experienced a reinfarction, compared with two group A patients. At discharge, eight patients were in functional class II and 10 in classes III and IV. In the PTCA group, 17 were in classes I and II and two each in classes III and IV. In the PTCA group, one patient died during the hospital phase and none died during the next 6 months, whereas in the control group, three patients died during the follow-up.
Patient 2 in group A developed complete cardiogenic shock within 31 hours after successful thrombolysis.9 After streptolysis, the myocardial perfusion was still borderline because of the critical stenosis in the one patent coronary vessel. The shock was reversed 30 minutes after the successful dilation improved coronary blood flow.
Surprisingly, the advancement of the balloon catheter through the stenotic area is much easier than was expected from our experiences with PTCA in patients with stable and unstable angina.8 9.22-24 Even if residual clot formation is present at the site of the previous occlusion, the organic material of the stenosis seems to be of a somewhat different, softer quality than that in patients with chronic stable angina. The 
